CONJUGATE VACCINE-INDUCED ANTIBODY ENHANCES PHAGOCYTOSIS OF TYPE-III GROUP-B STREPTOCOCCUS (III-GBS)

被引：0
作者：
CAMPBELL, JR [1 ]
BAKER, CJ [1 ]
EDWARDS, MS [1 ]
机构：
[1] BAYLOR COLL MED,HOUSTON,TX 77030
来源：
PEDIATRIC RESEARCH | 1994年 / 35卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：A294 / A294
页数：1
相关论文
共 50 条
[41]   INTRINSIC BACTERICIDAL CAPACITY OF PHAGOCYTOSIS AGAINST STREPTOCOCCUS GROUP-B OF TYPE-IA AND TYPE-III IN THE HUMAN NEWBORN [J].
LOPEZOSUNA, M ;
BECKER, ID ;
ROBINSON, OM ;
COLLADO, ML ;
KRETSCHMER, RR .
ARCHIVOS DE INVESTIGACION MEDICA, 1981, 12 (04) :S62-S62
[42]   FIBRONECTIN AND AGE-LIMITED SUSCEPTIBILITY TO TYPE-III, GROUP-B STREPTOCOCCUS [J].
PATTERSON, LER ;
BAKER, CJ ;
RENCH, MA ;
EDWARDS, MS .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (02) :471-474
[43]   COMPARISON OF ASSAYS FOR ANTIBODY TO GROUP-B-STREPTOCOCCUS, TYPE-III [J].
VOGEL, LC ;
BOYER, KM ;
GOTOFF, SP ;
KASPER, DL ;
BAKER, CJ .
JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (04) :530-530
[44]   A SIALIC-ACID DEFICIENT MUTANT OF TYPE-III GROUP-B STREPTOCOCCUS [J].
WESSELS, MR ;
BENEDI, VJ ;
RUBENS, CE ;
KASPER, DL .
CLINICAL RESEARCH, 1988, 36 (03) :A475-A475
[45]   ENDOCARDITIS CAUSED BY A GROUP-B STREPTOCOCCUS STRAIN, TYPE-III, IN A NONENCAPSULATED PHASE [J].
SELLIN, M ;
LINDERHOLM, M ;
NORGREN, M ;
HAKANSSON, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (09) :2471-2473
[46]   MECHANISM OF ALTERNATIVE COMPLEMENT PATHWAY INHIBITION BY TYPE-III GROUP-B STREPTOCOCCUS [J].
EDWARDS, MS ;
JENNINGS, HJ ;
NICHOLSONWELLER, A ;
KASPER, DL ;
BAKER, CJ .
CLINICAL RESEARCH, 1981, 29 (02) :A532-A532
[47]   TYPE-III GROUP-B STREPTOCOCCUS - FUNCTIONAL INTERACTION WITH IGG SUBCLASS ANTIBODIES [J].
GIVNER, LB ;
BAKER, CJ ;
EDWARDS, MS .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (03) :532-539
[48]   IMMUNOCHEMICAL CHARACTERIZATION OF NATIVE POLYSACCHARIDES FROM GROUP-B STREPTOCOCCUS - RELATIONSHIP OF TYPE-III AND GROUP-B DETERMINANTS [J].
KASPER, DL ;
GOROFF, DK ;
BAKER, CJ .
JOURNAL OF IMMUNOLOGY, 1978, 121 (03) :1096-1105
[49]   INTRAVENOUS IMMUNOGLOBULIN ENHANCES THE DEPOSITION OF IGG AND C3 ONTO TYPE-III GROUP-B STREPTOCOCCUS [J].
ROBINSON, T ;
TANNER, JE ;
BROWN, MS ;
HALL, DC ;
CHRISTENSEN, RD ;
LASSITER, HA .
CLINICAL RESEARCH, 1990, 38 (04) :A976-A976
[50]   RIFAMPIN TREATMENT OF INFANT RATS NASALLY COLONIZED WITH TYPE-III GROUP-B STREPTOCOCCI (GBS) [J].
DELAPLANE, D ;
SHULMAN, ST ;
YOGEV, R .
CLINICAL RESEARCH, 1983, 31 (04) :A788-A788
12345